256 related articles for article (PubMed ID: 36377878)
1. Oral Immunization with Attenuated
Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
[TBL] [Abstract][Full Text] [Related]
2. Recombinant-attenuated Salmonella enterica serovar Choleraesuis vector expressing the PlpE protein of Pasteurella multocida protects mice from lethal challenge.
Zhou G; Tian J; Tian Y; Ma Q; Li Q; Wang S; Shi H
BMC Vet Res; 2023 Aug; 19(1):128. PubMed ID: 37598169
[TBL] [Abstract][Full Text] [Related]
3. Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.
Wang Y; Wang J; Zhou M; Liu P; Zhang E; Li Y; Lin J; Feng Z; Yang Q
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31492763
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
[TBL] [Abstract][Full Text] [Related]
5. Oral Immunization with Attenuated
Zhang G; Fu Y; Li Y; Li Q; Wang S; Shi H
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136597
[TBL] [Abstract][Full Text] [Related]
6. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenicity of attenuated Salmonella choleraesuis vaccine strain expressing immunogenic genes of Mycoplasma hyopneumoniae in mice].
Ma F; Zou H; He Q
Wei Sheng Wu Xue Bao; 2011 Sep; 51(9):1270-7. PubMed ID: 22126084
[TBL] [Abstract][Full Text] [Related]
8. Salmonella enterica serovar Choleraesuis vector outperforms alum as an adjuvant, increasing a cross-protective immune response against Glaesserella parasuis.
Li YA; Sun Y; Zhang Y; Wang X; Dieye Y; Wang S; Shi H
Vet Microbiol; 2023 Dec; 287():109915. PubMed ID: 38000209
[TBL] [Abstract][Full Text] [Related]
9. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
[TBL] [Abstract][Full Text] [Related]
10. A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice.
Gao Z; Chen L; Song T; Pan X; Li X; Lu G; Tang Y; Wu X; Zhao B; Zhang R
Vaccine; 2022 Apr; 40(16):2370-2378. PubMed ID: 35307227
[TBL] [Abstract][Full Text] [Related]
11. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
[TBL] [Abstract][Full Text] [Related]
12. Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2.
Tao Y; Yang R; Shu J; Zheng W; Chen J; Wu Y; He Y
BMC Vet Res; 2020 Sep; 16(1):342. PubMed ID: 32938456
[TBL] [Abstract][Full Text] [Related]
13. Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.
Maes D; Boyen F; Devriendt B; Kuhnert P; Summerfield A; Haesebrouck F
Vet Res; 2021 May; 52(1):67. PubMed ID: 33964969
[TBL] [Abstract][Full Text] [Related]
14. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration.
Hao F; Bai Y; Xie X; Yuan T; Wei Y; Xiong Q; Gan Y; Zhang L; Zhang Z; Shao G; Feng Z
Vaccine; 2022 Oct; 40(42):6074-6083. PubMed ID: 36109278
[TBL] [Abstract][Full Text] [Related]
16. Recombinant secreted antigens from Mycoplasma hyopneumoniae delivered as a cocktail vaccine enhance the immune response of mice.
Galli V; Simionatto S; Marchioro SB; Klabunde GH; Conceição FR; Dellagostin OA
Clin Vaccine Immunol; 2013 Sep; 20(9):1370-6. PubMed ID: 23803903
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice.
Chen AY; Fry SR; Forbes-Faulkner J; Daggard G; Mukkur TKS
J Med Microbiol; 2006 Jul; 55(Pt 7):923-929. PubMed ID: 16772421
[TBL] [Abstract][Full Text] [Related]
18. The immune mechanism of Mycoplasma hyopneumoniae 168 vaccine strain through dendritic cells.
Shen Y; Hu W; Wei Y; Feng Z; Yang Q
BMC Vet Res; 2017 Sep; 13(1):285. PubMed ID: 28915878
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs.
Bourry O; Fablet C; Simon G; Marois-Créhan C
Vet Microbiol; 2015 Nov; 180(3-4):230-6. PubMed ID: 26422712
[TBL] [Abstract][Full Text] [Related]
20. Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice.
Li Q; Lv Y; Li YA; Du Y; Guo W; Chu D; Wang X; Wang S; Shi H
Vaccine; 2020 Oct; 38(44):6904-6913. PubMed ID: 32907758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
